Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis

    Research output: Contribution to journalJournal articlepeer-review

  2. Organotypic Culture of Testicular Tissue from Infant Boys with Cryptorchidism

    Research output: Contribution to journalJournal articlepeer-review

  3. Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma

    Research output: Contribution to journalJournal articlepeer-review

  1. Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins

    Research output: Contribution to journalJournal articlepeer-review

  2. How a Medical Association Can Make a Difference in a Crisis Situation

    Research output: Contribution to journalJournal articlepeer-review

  3. Human cytomegalovirus hijacks host stress response fueling replication stress and genome instability

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

Complete surgical resection of glioblastoma is difficult due to the invasive nature of this primary brain tumor, for which the molecular mechanisms behind remain poorly understood. The three human ELMO genes play key roles in cellular motility, and have been linked to metastasis and poor prognosis in other cancer types. The aim of this study was to investigate methylation levels of the ELMO genes and their correlation to clinical characteristics and outcome in patients diagnosed with glioblastoma. To measure DNA methylation levels we designed pyrosequencing assays targeting the promoter CpG island of each the ELMO genes. These were applied to diagnostic tumor specimens from a well-characterized cohort of 121 patients who received standard treatment consisting of surgery, radiation therapy, plus concomitant and adjuvant chemotherapy. The promoter methylation levels of ELMO1 and ELMO2 were generally low, whereas ELMO3 methylation levels were high, in the tumor biopsies. Thirteen, six, and 18 biopsies were defined as aberrantly methylated for ELMO1, ELMO2, and ELMO3, respectively. There were no significant associations between the methylation status of any of the ELMO gene promoter CpG islands and overall survival, progression-free survival, and clinical characteristics of the patients including intracranial tumor location. Therefore, the methylation status of the ELMO gene promoter CpG islands is unlikely to have prognostic value in glioblastoma.

Original languageEnglish
JournalInternational Journal of Molecular Sciences
Volume19
Issue number3
Pages (from-to)679
Number of pages13
ISSN1661-6596
DOIs
Publication statusPublished - 28 Feb 2018

ID: 54781724